Xuan Wu
Tongji University(CN)University of Science and Technology of China(CN)East China University of Science and Technology(CN)University of Electronic Science and Technology of China(CN)Wuhan University of Technology(CN)National University of Computer and Emerging Sciences(PK)Huazhong Agricultural University(CN)Beijing Jiaotong University(CN)Wenzhou Medical University(CN)First Affiliated Hospital of Wenzhou Medical University(CN)Zhengzhou University(CN)Wenzhou Hospital of Traditional Chinese Medicine(CN)Chengdu Women's and Children's Central Hospital(CN)Shanghai CASB Biotechnology (China)(CN)Peking University Shenzhen Hospital(CN)First Affiliated Hospital of Chongqing Medical University(CN)General Hospital of Shenyang Military Region(CN)Henan Provincial People's Hospital(CN)Wuhan Third Hospital(CN)Zhengzhou Institute of Emerging Industrial Technology(CN)First Affiliated Hospital of Henan University(CN)Emerging Concepts (United States)(US)Tongji Hospital(CN)Qilu Hospital of Shandong University(CN)Huazhong University of Science and Technology(CN)China Agricultural University(CN)Dalian Jiaotong University(CN)Zhejiang University(CN)Yangzhou University(CN)Nanjing Medical University(CN)Chongqing Medical University(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer-related molecular mechanisms research, Nanoplatforms for cancer theranostics, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial(2016)520 cited
- → Patients with Exon 19 Deletion Were Associated with Longer Progression-Free Survival Compared to Those with L858R Mutation after First-Line EGFR-TKIs for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis(2014)171 cited
- → Subchronic Alpha-Linolenic Acid Treatment Enhances Brain Plasticity and Exerts an Antidepressant Effect: A Versatile Potential Therapy for Stroke(2009)140 cited
- → Clinicopathological and prognostic significance of programmed cell death ligand1 (PD-L1) expression in patients with non-small cell lung cancer: a meta-analysis.(2015)139 cited
- → Network Meta-Analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations(2014)133 cited